Try our Advanced Search for more refined results
March 01, 2012
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al
Case Number:
1:12-cv-00258
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 06, 2012
Avanir Targets Watson In Suit Over Nuedexta Patents
Avanir Pharmaceuticals Inc. sued drugmaker Watson Pharmaceuticals Inc. in Delaware on Friday in an effort to block plans to market a generic version of so-called involuntary emotion drug Nuedexta, the latest in a campaign of patent suits over the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login